DEMAND DIVERSITY C.I.C.

Company limited by guarantee

Company Registration Number:
14740687 (England and Wales)

Unaudited statutory accounts for the year ended 31 March 2024

Period of accounts

Start date: 20 March 2023

End date: 31 March 2024

DEMAND DIVERSITY C.I.C.

Contents of the Financial Statements

for the Period Ended 31 March 2024

Balance sheet
Additional notes
Community Interest Report

DEMAND DIVERSITY C.I.C.

Balance sheet

As at 31 March 2024

Notes 2024


£
Fixed assets
Intangible assets:   0
Tangible assets:   0
Investments:   0
Total fixed assets: 0
Current assets
Stocks:   0
Debtors:   0
Cash at bank and in hand: 0
Investments:   0
Total current assets: 0
Prepayments and accrued income: 0
Creditors: amounts falling due within one year:   0
Net current assets (liabilities): 0
Total assets less current liabilities: 0
Creditors: amounts falling due after more than one year:   0
Provision for liabilities: 0
Accruals and deferred income: 0
Total net assets (liabilities): 0
Members' funds
Profit and loss account: 0
Total members' funds: 0

The notes form part of these financial statements

DEMAND DIVERSITY C.I.C.

Balance sheet statements

For the year ending 31 March 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen not to file a copy of the company's profit and loss account.

This report was approved by the board of directors on 2 December 2024
and signed on behalf of the board by:

Name: Ashish Rishi
Status: Director

The notes form part of these financial statements

DEMAND DIVERSITY C.I.C.

Notes to the Financial Statements

for the Period Ended 31 March 2024

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

DEMAND DIVERSITY C.I.C.

Notes to the Financial Statements

for the Period Ended 31 March 2024

  • 2. Employees

    2024
    Average number of employees during the period 0

COMMUNITY INTEREST ANNUAL REPORT

DEMAND DIVERSITY C.I.C.

Company Number: 14740687 (England and Wales)

Year Ending: 31 March 2024

Company activities and impact

Demand Diversity is a not-for-profit organisation dedicated to driving meaningful change within the clinical research industry by advocating for authentic diversity and inclusion. Over the financial year, the organisation has focused on identifying and addressing systemic barriers that prevent underrepresented populations from participating in clinical trials. This has been done through research, targeted campaigns, educational initiatives, and actionable guidance for stakeholders. Demand Diversity has worked to ensure that clinical trials reflect the diverse communities they are designed to serve. The organisation has collaborated closely with community groups to raise awareness about the importance of diversity in clinical trials, sharing evidence-based insights and practical strategies for improvement. By creating platforms for dialogue and delivering impactful advocacy, Demand Diversity has played a crucial role in catalysing action across the industry. The organisation’s activities have directly benefited the community by increasing the representation of underserved populations in clinical research. This ensures that medical advancements are more equitable and effective for all, helping to reduce health disparities and foster trust in healthcare systems among marginalised groups. By championing inclusivity, Demand Diversity has contributed to a broader societal shift towards fairness and equity in healthcare.

Consultation with stakeholders

Demand Diversity recognises the critical importance of engaging with a wide range of stakeholders to advance diversity and inclusion within clinical research. Key stakeholders include underrepresented communities whose participation in clinical trials is essential for achieving comprehensive and equitable research outcomes, as well as clinical trial sponsors and researchers who design and implement studies. Healthcare providers, who play a vital role in patient care and recruitment for trials, are also central to these efforts, alongside policymakers and regulatory bodies that influence the guidelines governing clinical research. Advocacy groups and non-governmental organisations dedicated to health equity and patient rights further contribute to this ecosystem. Throughout the year, Demand Diversity has actively consulted its stakeholders through various methods. Community engagement initiatives, such as forums, workshops, and focus groups, have been integral in understanding the barriers faced by underrepresented populations. Collaborative partnerships with sponsors, researchers, and healthcare providers have provided valuable insights into the development of inclusive research protocols and recruitment strategies. Additionally, the organisation has worked closely with policymakers, advocating for regulatory frameworks that prioritise diversity. Surveys and feedback mechanisms have also been employed to gather perspectives from stakeholders, ensuring their voices shape the organisation’s strategic direction. In response to the feedback received, Demand Diversity has undertaken several impactful actions. Educational resources have been developed to raise awareness about the importance of diversity in clinical trials among both professionals and the public. Training programmes have been implemented to equip researchers and healthcare providers with the tools needed to engage with communities in culturally sensitive and effective ways. Communication channels have also been enhanced to foster ongoing dialogue with stakeholders, ensuring their continued involvement in shaping the organisation’s initiatives. These efforts have not only strengthened relationships with stakeholders but also enhanced the impact of Demand Diversity’s work in fostering inclusivity within clinical research. The consultations have ensured that the organisation’s strategies remain grounded in the needs and perspectives of those it serves.

Directors' remuneration

No remuneration was received

Transfer of assets

No transfer of assets other than for full consideration

This report was approved by the board of directors on
2 December 2024

And signed on behalf of the board by:
Name: Ashish Rishi
Status: Director